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 Mitochondria (see box on page XX) are far more than the power plants of our cells. 
Few people realize that these tiny structures play a central role in our physiology in various 
contexts and maintain a complex, synergistic relationship with the nuclear genome. 
Molecular dermatologist Birch-Machin is among those who do. 
 And in studying the functions of mitochondria in human skin, Birch-Machin recently 
made an eye-opening discovery that is critically important to both mitochondrial and skin 
health in chronologic and photoaging. It concerns the unexpected protective role of 
complex II—the diminutive, unassuming member of the respiratory enzyme chain that 
completes conversion of the energy from glucose to ATP (see box on page XX). The 
implications are profound for understanding what can go wrong and why, and for 
developing therapeutic interventions to slow chronological aging, protect against 
photoaging, and reverse existing concerning changes.   
 
Getting Hooked on Mitochondria—And Then the Skin 
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 When Birch-Machin finished his PhD in molecular biology in 1986, he chose a post-
doctoral fellowship with mitochondrial expert Professor Sir Doug Turnbull at the University 
of Newcastle in the U.K. Turnbull—now Director of the Wellcome Trust Centre for 
Mitochondrial Research there—was dedicated to uncovering the molecular mechanisms 
responsible for mitochondrial diseases. “I was very much impacted by the illnesses 
associated with mitochondrial dysfunction,” Birch-Machin recalls. “Children with these 
diseases died very early, and it was devastating.” He has been committed to understanding 
mitochondrial dysfunction ever since, with the ultimate goal of finding ways to correct it.  
 For the next decade Birch-Machin focused on pediatric mitochondrial myopathies, with 
assignments in the U.S., Canada, and then Paris. Along the way, he began to develop 
innovative techniques for gaining information about the mitochondrial genome. Then, while 
he was at the Hôpital Necker for Sick Children in Paris, the Department of Dermatology at 
the University of Newcastle expressed interest in having him apply his research techniques 
to mitochondria in human skin.  
 As he considered this, Birch-Machin began to think about the skin’s role of 
“communicating with the environment—and I had a kind of epiphany,” he recalls. “I knew 
from my mitochondrial research in muscle and brain that mitochondria play a role in 
chronologic aging, which involves declining metabolic energy and increasing oxidative 
stress. I also knew that mitochondria don’t repair very well,” he continues—“and it occurred 
to me that mitochondrial damage in the skin most likely increases measurably with sun 
exposure. I became really excited to study the role of mitochondria in skin aging, and also 
understand the effect that sun exposure has on this normal process. No one had explored 
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this before—and I wanted to do it.” Birch-Machin has focused on the skin ever since, 
expanding understanding in ways that will ultimately influence patient care. 
 
mtDNA Damage—Biomarker of Cumulative UV Radiation Exposure 
 Specific properties of the mitochondrial genome had led Birch-Machin to hypothesize 
that mtDNA damage accurately reflects the cumulative impact of sun exposure. 
Mitochondrial genes lack the histone covers that are important protectors of nuclear genes, 
and their repair mechanisms are limited. The genome is also in close physical proximity to 
where superoxide generation—which occurs during UV exposure—takes place. So the 
mitochondrial genome is multiply vulnerable, and its limited repair capabilities allow 
damage to accumulate over time. The extent of this underlying damage, though, is not 
manifest. Because there are a great many nonclonal mitochondria within individual cells and 
multiple genomes within each mitochondrion (see box on page XX), there are usually 
enough molecules of functional mtDNA to compensate for those with mutations and 
maintain cell functions. But Birch-Machin suspected that assessing the extent of these 
silenced mutations should provide measurable evidence of UV-induced damage to mtDNA, 
and that the extent of damage would increase with increasing UV exposure—ie, it would be 
a highly sensitive biomarker of UV exposure in human skin.  
  Previous studies had examined the frequency of just a single common deletion. But 
Birch-Machin believed that a complete picture was the only accurate way to begin. He and 
his team assessed 71 split-skin samples taken from body areas that were either unexposed, 
intermittently exposed, or highly sun exposed, and identified the full spectrum of mtDNA 
deletions in each skin sample. The number of deletions in the epidermis increased 
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significantly as UV exposure increased, but mtDNA in the dermis showed no effect. Next, 
they focused on a single, rarely reported 3895 bp mtDNA deletion in age-matched skin 
samples, again from body areas with large differences in sun exposure. The frequency of this 
rare deletion increased in line with increasing UV exposure—this time in both the epidermis 
and dermis. Exposing cultured human fibroblasts to a UVA+UVB light source confirmed this. 
The same rare mtDNA deletion appeared, then its presence increased in response to 
continued exposure.  
 Next, Birch-Machin and his team determined that the shorter UVR wavelengths (>320 
nm) are primarily responsble for this mtDNA damage—the same part of the spectrum 
already implicated in both UVR-induced erythema and nuclear DNA damage in the skin. 
This time, dermal fibroblasts turned out to be far more sensitive to sun-induced mtDNA 
damage than keratinocytes, a discovery that  holds “important implications for disease and 
photodamage mechanisms and for interventions,” Birch-Machin points out.  
   
Complex II—Newly Recognized Importance in Skin  
 The four respiratory chain enzymes—complex I through complex IV—gradually 
transform the energy from glucose into ATP (see box on page XX). The byproducts of this 
process also make them the major generator of cellular oxidative stress. mtDNA 
vulnerability to this stress results in damage that in turn reduces the mitochondrias’ ability 
to repair themselves, which increases the production of mutations and dysfunction, which 
further increases ROS production, which diminishes repair capabilities still further, producing 
additional mutations…. This vicious cycle is thought to underlie the mitochondrias’ 
contribution to aging, cancer, neurodegeneration, and cell death in many tissues.  
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 Birch-Machin and his group had already shown that UVA exposure increases both ROS 
production and mtDNA mutations in human skin. Now he wanted to begin exploring its role 
in this vicious cycle by identifying the most important sites of ROS production within the 
mitochondrial respiratory chain. Although he was not the first investigator to pose this 
question, he was among the very few to explore it in skin and the first to pursue it in human 
skin. Birch-Machin found this lack of attention to human skin quite surprising, “given that 
the skin is regularly exposed to the harmful UVA rays in sunlight.”  
 He and his team created multiple cultures of human keratinocytes (from the 
immortalized HaCaT cell line) and of fibroblasts (from neonatal foreskin). Each of the four 
respiratory chain enzymes can be inhibited by several chemical agents, and Birch-Machin 
modified the individual cultures by adding, separately, each of these inhibitors. Then he 
exposed these cultures to doses of UVA irradiation that are comparable to normal outdoor 
exposure. Representative cultures were left unexposed as controls. The expectation was that 
among the various UVA-exposed cultures, the missing enzyme associated with the largest 
drop in UVA-induced ROS production would—under normal circumstances—be the largest 
contributor to ROS production.  
 The results took them in a very different direction. Complex II stood out—but not for 
producing the lion’s share of ROS. Instead, it was unique for its ability to suppress ROS 
production, because inhibiting its activity increased ROS levels considerably.  
 Birch-Machin also engineered a comparison of young and aging tissues to see if the 
levels of these respiratory chain enzymes change with age. Shrinking telomeres are 
considered to be a biomarker of aging, so he and his team used cultures grown from two 
versions of human fetal lung fibroblasts. The youthful tissue cultures were grown from 
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fibroblasts engineered to overexpress the telomerase enzyme, which lengthens telomeres at 
the ends of nuclear genes. Because the unaltered—wild-type—cells had shorter telomeres, 
in relative terms they represented aging tissue. Assessing the individual levels of complexes 
I-IV in the young and aging fibroblast cultures highlighted complex II again. It was the only 
respiratory chain enzyme showing decreased activity in the aging lung fibroblasts. In line 
with this, recent data from a lab using mice to study aging skin in vivo had shown a 
decrease in complex II activity along with an increase in senescent cells in the skin as mice 
aged. 
 Birch-Machin realized for the first time that “the effect of complex II in human skin cells 
may be significantly more important than previously thought.” It would explain why the 
activity of this tiny enzyme activity is approximately two-fold greater in skin cells than in the 
liver, for example. Compex II also differs from the other three respiratory chain enzymes in a 
fundamental way. All of its subunits and assembling proteins are produced exclusively by 
the nuclear genome.  
 
Pursuing the Aging Connection 
 Birch-Machin wasted no time in following up on this observation that “younger” fetal 
lung fibroblasts contained more complex II than the “older” ones did. “It is highly important 
to understand the aging process in skin,” he emphasizes. “Skin is the largest organ of the 
body, acting as a protective barrier to a spectrum of external insults that includes UV 
radiation, infection, toxicity, and mechanical stress,” he points out. A better understanding 
of the underlying biology will enable maintenance of skin health. And beyond this, “the skin 
is an organ that can be accessed and studied easily, and thus what is learned from this 
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research may have profound relevance and application to aging in other body tissues,” he 
adds. 
 To explore the role of complex II in skin aging, Birch-Machin and his team worked with 
foreskin tissue (sun-protected, eliminating any influence of UV exposure) from 27 males 
ranging from 6 to 72 years of age. They studied skin aging from two perspectives. Biological 
aging concerns the functional decline of the entire organism over time. Cellular senescence 
involves the transformation of proliferating cells to a state of irreversible growth arrest. On 
the positive side, senescence is an important tumor suppressive mechanism by preventing 
potentially malignant cells from undergoing replication, and senescent cells produce 
cytokines that aid wound healing. But senescent cells also have a number of significant 
negative effects—including ROS production and secretion of inflammatory cytokines—and 
thus are thought to be prominent in the aging process.   
 Biological aging: Birch-Machin and his team cultured fibroblasts and keratinocytes 
from each of these skin samples, then precisely calculated the activity level of complex II per 
unit of mitochondria in every culture. They also measured gene transcript expression and 
protein levels for complex II. Results were compared with complex IV, chosen as the control 
because—unlike complexes I and III—it is not directly linked to complex II within the 
electron transport chain. When the results were in, it became clear that complex II activity is 
pivotal to fibroblast function—but not to keratinocytes.  
 To begin with, complex II activity was substantially greater in fibroblasts than in 
keratinocytes, up to twice as high in cell cultures from younger donors. In addition, complex 
II activity decreased steadily with donor age—but only in fibroblasts. Because gene 
transcript expression and protein levels for complex II also declined with age in fibroblasts, it 
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appeared that in fibroblasts from this sun-protected area, the enzyme itself had not lost 
effectiveness with age but there was less and less of it. With the increasing loss of complex 
II’s protective actions, ROS-caused damage would exacerbate this diminishing activity. 
Complex IV showed no relation to age in either cell culture. 
 Senescence: When Birch-Machin and his team turned their attention to the relationship 
between senescence, complex II, and biological age in human skin, the ensuing results shed 
light on their observations with biological aging. Fibroblast cultures from 15 of the initial 
donors (ages 6-71 years) were separated into senescent and nonsenescent cell populations 
using the senescence biomarker lipofuscin, a wear-and-tear fluorescent pigment that is a 
remnant of the transformation to senescence. As donor age increased, the number of 
senescent fibroblasts increased while the activity level of complex II decreased—but only in 
senescent fibroblasts. (Complex IV activity level in senescent fibroblasts was unrelated to 
donor age.) The surprise was that purely nonsenescent fibroblast cultures showed no 
correlation between aging and complex II activity.  
 These unexpected results refocused the initial picture. The age-related decrease in 
complex II activity observed in the original fibroblast cultures did not actually reflect the 
entire fibroblast population, but was specifically a function of the senescent cell subset. 
Isolating the senescent fibroblasts for study emphasized that—in terms of mitochondrial 
complex II activity—senescent fibroblasts in the skin of older individuals are less efficient 
than those in younger individuals. 
 Human in vivo data will be required to confirm and flesh out the role of decreasing 
complex II activity in skin aging, and clarify whether this loss is a cause or a consequence of 
aging—or both, as the vicious cycle of aging would predict. Any of these scenarios, 
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including direct DNA damage initiated by increased ROS production, is likely to increase 
overall mitochondrial dysfunction. And the result is decreased tissue function.  
 
Testing Interventions 
 Because antioxidant compounds neutralize ROS, thus reducing or eliminating oxidative 
damage, this is a logical area to explore for candidates to support skin health and prevent 
further damage in the face of ROS-inducing conditions. Birch-Machin has begun evaluating 
candidates from medicinal plants and plant extracts and from chemical molecules. 
  Clitoria ternatea L:  Birch-Machin learned of C. ternatea—the butterfly pea plant—
from Dr. Edward Okello, a neurology colleague who is also Executive Director of the 
Medicinal Plant Research Group. Indigenous to tropical Asia, it spread more widely across 
Asia and to Latin America and the East and West Indies, and has extensive traditional uses. 
One involves an herbal tea made from the colorful blue and white flower that is taken to 
protect the skin against age-related changes and sun-induced damage. Research on the 
plant’s biological activities have focused on the root, seeds, and leaf, but the flower was 
recently found to contain anthocyanins, which are known antioxidants.  
 Birch-Machin incubated human keratinocyte cultures with the flower water extract 
(CTW), then rinsed them before exposure to hydrogen peroxide or UV. There was 
significantly less cytotoxicity and mtDNA damage after CTW treatment than in nontreated 
cells. A phytochemical analysis of the flower identifed major concentrations of polyacylated 
anthocyanins and flavonol glycosides, both with widely documented antioxidant actions. 
Birch-Machin points out that the flower extract’s significant ability to reduce UV-induced 
mtDNA damage indicates a potential for preventing oxidative stress arising from 
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mitochondrial dysfunction. Further research for therapeutic benefits is warranted. “We will 
also be studying additional Malaysian species, working in conjunction with Kew Gardens in 
London,” Birch-Machin says. 
 Antioxidant molecules: The first round of experiments compared the protective 
capability of two antioxidant molecules able to penetrate the mitochondria. MitoQ 
(mitoquinone)—a modified ubiquinone molecule developed by Mike Murphy, PhD, 
Program Leader of the MRC Mitochondrial Biology Unit, University of Cambridge, UK—is 
actively and exclusively attracted to mitochondria, and sufficiently small to penetrate the 
mitochondrial membrane. Tiron is a mitochondria-permeable and localized superoxide 
scavenger and antioxidant and also chelates metals (including iron and titanium). Human 
fibroblast cultures were incubated with one or the other, then exposed to physiologic doses 
of UVA or to hydrogen peroxide. Tiron completely prevented ROS-induced mtDNA damage 
across the board. MitoQ reduced damage by 17% and 32%, respectively. Birch-Machin 
suspected that tiron’s complete elimination of ROS production indicated a protective effect 
extending beyond the mitochondria, and further exploration also demonstrated complete 
protection of the nuclear genome from hydrogen peroxide-induced damage. MitoQ 
achieved 18%. Birch-Machin showed that it is completely independent of the Nrf2sigaling 
pathway, which is known to provide cellular protection against oxidative stress.  
 Tiron completely abrogated mitochondrial and nuclear DNA damage in human skin 
cells exposed to these stressors. “We postulated that these profound in vitro antioxidant 
effects are attributable to the combination of its antioxidant and metal-chelating 
properties,” Birch-Machin explains. “It targets not just the ROS, but also the increased free 
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intracellular metals that are released due to oxidative insults.” This points to the ideal 
therapeutic strategy of combining compounds with complementary capabilities.  
   
Conclusions 
 It had first been speculated in the early 1970s that mitochondria play a key role in the 
aging process. Birch-Machin’s research in the skin “brings us one step closer to 
understanding how mitochondria may be contributing to this, with the hope of eventually 
targeting areas of the mitochondria in an attempt to counteract the signs of aging,” he 
states. This includes his search for a way to maintain ideal levels of complex II as an 
endogenous ROS suppressor, and his continuing work using tiron as a preventive. 
 He is also expanding his pursuit of mtDNA involvement in skin health and disease. He 
is looking at mtDNA in the context of treating psoriasis, in the relationship between 
oxidative stress, nutritional status, and skin aging, and in the science and use of sunscreens. 
 Birch-Machin is not mitochondria-centric though. “The fascination and beauty for me,” 
he explains, “is the way the two genomes communicate and affect each other. Those who 
focus on just one of them and ignore the other—it’s at their peril,” he adds. “Our 
perspective should be a healthy balance between the two, as they are equally important.” 
 
 
SIDEBAR 1 
Mitochondria—The Tiny Organelles With the Huge Punch 
 Back in the mists of evolutionary time, our mitochondria—the cellular organelles in our 
cytoplasm that produce 90% of the chemical energy that our cells need to survive, and 
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contribute substantially to other basic cellular functions—were independently dwelling 
purple photosynthetic bacteria. As eukaryotes evolved more than 1 billion years ago, these 
free-living bacteria became incorporated within them—the process of endosymbiosis—and 
developed a mutually dependent relationship. Their genomes, though, remained 
independent entities and mitochondria replication is independent of cell division. The 
human nuclear genome now contains 3 billion base pairs, with only about 2% actually 
coding for its 20,000 genes. The mitochondrial genome (mtDNA) evolved in the opposite 
direction, contracting down to a 16.5-kb circular structure containing just 16,569 base pairs 
and 37 genes (see illustration on page XX). Unlike nuclear DNA, mtDNA is a model of 
efficiency with no introns and no spacing between genes, so that almost all of it (∼93%) 
represents a coding region. These dual-membrane mitochondria are rich in fats, proteins, 
and enzymes, but some of the proteins essential to their function—including the entire 
complex II respiratory enzyme (see box on page XX)—are produced by the cell, not by the 
mitochondria. 
 What this genome lacks in size, it makes up for in exceptional numbers. Excluding 
mature red blood cells, which are unique in their absence of mitochondria, the individual 
cellular presence of these organelles ranges from around 1,000 in cells with lower ATP 
needs to roughly 7,000 in individual human myocytes. Adding it all up, we contain roughly 
500 trillion mitochondria, accounting for roughly 30% of our body weight. And each 
individual mitochondrion holds from 1 to 15 mtDNA molecules. Each cell’s population is not 
clonal, but include normal—ie, wild-type—and various mutation-altered states. The 
presence of wild-type genomes is potent. “There can actually be quite profound deficiencies 
and damage present, but the remaining wild-type genomes will complement the damaged 
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ones,” Birch-Machin explains. “In some cases, just 10% of the mitochondrial genomes need 
to be normal to make up for the deficiencies of the other 90%.”   
 Although mitochondria are most well known as the cell’s powerhouse—transforming 
the energy from glucose into ATP—this is just part of what they do. Among other things, 
they participate in cellular differentiation, cell growth, the cell cycle, apoptosis, and steroid 
synthesis. They are platforms for intracellular signaling, regulators of innate immunity, 
modulators of stem cell activity, and are host to numerous biosynthetic and signaling 
processes that ultimately couple cellular metabolism to homeostatic regulatory mechanisms. 
Dysfunctional mitochondria are thus responsible for a number of human diseases and 
conditions. This past summer, mitochondrial research at the University of Southern 
California documented cross-regulation between the nuclear and mitochondrial genomes—
noting that sometimes it’s the mitochondrial DNA in charge. 
 
 
 
SIDEBAR 2 
The Power of Complex II 
 Complex II is tiny—only four subunits in size—but particularly powerful because it is 
involved in two phases of the progression from glucose to ATP, not just one. Yet 
mitochondrial researchers have learned this only recently. They had paid scant attention to 
complex II because it is so much smaller than the other respiratory chain enzymes, which 
contain from 10 to 45 subunits. But its minimal size disguises immense impact—far greater 
than the other three complexes—because it is involved in the Krebs cycle as well as the 
electron transport chain. “Because it is involved in two major metabolic pathways,” Birch-
Machin explains, “a small change in this enzyme has a profound effect.” 
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 There are three steps in producing ATP, which begins with the release of energy from 
glucose. Then the Krebs—citric acid—cycle breaks this energy down and stores it in carrier 
molecules, enabled by complex II’s contribution of reduced ubiquinone. In the final stage of 
aerobic respiration—the electron transport stage—the respiratory chain enzymes complexes 
I, III, and IV engineer the production of ATP and enable it to leave the mitochondria. This 
involves electron transfers, proton gradients, and oxygen, producing reactive oxygen species 
(ROS) as byproducts. Complex II participates by—as Birch-Machin has discovered— 
minimizing ROS production and damage. Chronic oxidative stress has been linked to a 
myriad of pathologies.     
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